We of course just got those big earnings, but for me the Eli Liy story was a big one. They dropped their major latestage trial results for their new obesity drug, which is called Retatrich, showing that patients lost nearly 30% of their body weight. Now, that far exceeds the performance of any of the current treatments on the market.The data also showed some meaningful relief from knee pain and osteoarthritis patients, underscoring the drug's broad potential impact on patient health. We did see shares of El ...